Nova Patents
AP3628A

A novel formulation of indomethacin

Abstract

The present invention relates to methods for producing particles of indomethacin using dry milling processes as well as compositions comprising indomethacin, medicaments produced using indomethacin in particulate form and/or compositions, and to methods of treatment of an 5 animal, including man, using a therapeutically effective amount of indomethacin administered by way of said medicaments.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

Every citation, both waysCites: the store holds 4 of 5

Citations
DocumentRelationOfficeCited during
WO2007070851A2CitesWorld Intellectual Property Organization (WIPO)Search report
WO2008000042A1CitesWorld Intellectual Property Organization (WIPO)Search report
WO2008000042A1CitesWorld Intellectual Property Organization (WIPO)–
WO2007070851CitesWorld Intellectual Property Organization (WIPO)–
GUPTA, M.K ET AL.: "Formation of Physically Stable Amorphous Drugs by Milling with Neusilin", JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 92, 3 March 2003 (2003-03-03), pages 536 - 551, XP002496655, DOI: doi:10.1002/jps.10308Non-patent–Search report
BAHL, D. ET AL.: "Amorphization of Indomethacin by Co-Grinding with Neusilin US2: Amorphization Kinetics, Physical Stability and Mechanism", PHARMACEUTICAL RESEARCH, vol. 23, no. 10, October 2006 (2006-10-01), pages 2317 - 2325, XP019437051Non-patent–Search report